Publications by authors named "Per Sonne Holm"

15Publications

Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer.

J Exp Clin Cancer Res 2019 Jul 22;38(1):322. Epub 2019 Jul 22.

Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675, München, Germany.

View Article and Find Full Text PDF
July 2019

Adenovirus Particle Quantification in Cell Lysates Using Light Scattering.

Hum Gene Ther Methods 2017 10 14;28(5):268-276. Epub 2017 Aug 14.

1 Klinikum Rechts der Isar, Technische Universität München , Klinik und Poliklinik für Urologie, München, Germany.

View Article and Find Full Text PDF
October 2017

YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.

J Transl Med 2013 Sep 18;11:216. Epub 2013 Sep 18.

Institut für Experimentelle Onkologie & Therapieforschung, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str, 22, 81675 München, Germany.

View Article and Find Full Text PDF
September 2013

Engineering magnetic nanoparticles and formulations for gene delivery.

J Control Release 2010 Nov;148(1):e63-4

Klinikum rechts der Isar, Institute for Experimental Oncology and Therapy Research, Technische Universität München, Ismaninger Str 22, 81675 Munich, Germany.

View Article and Find Full Text PDF
November 2010

Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.

Int J Oncol 2007 Aug;31(2):419-30

Institute of Pathology, Charité Campus Mitte, Humboldt University Berlin, D-10117 Berlin, Germany.

View Article and Find Full Text PDF
August 2007

Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1.

Biochem Biophys Res Commun 2007 May 2;357(1):295-301. Epub 2007 Apr 2.

Charité Campus Mitte, Institute of Pathology, Charitéplatz 1, D-10117 Berlin, Germany.

View Article and Find Full Text PDF
May 2007

Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development.

J Virol 2006 Apr;80(8):3904-11

Institut fuer Experimentelle Onkologie und Therapieforschung, Technische Universitaet Muenchen, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany.

View Article and Find Full Text PDF
April 2006

Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells.

Oncogene 2004 Jan;23(4):945-55

Institute of Pathology, Charité, Campus Mitte, Humboldt University Berlin, Schumannstr 20/21, Berlin D-10117, Germany.

View Article and Find Full Text PDF
January 2004